Nuwellis (STU:22S1) Valuation Rank


STU:22S1 Nuwellis Inc STU:22S1
19 GF Score
Price €6,554.73
! 3 Warning Signs
View Full Analysis

What is Nuwellis Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Nuwellis Valuation Rank Related Terms

STU:22S1
19GF Score
Nuwellis Inc STU:22S1
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nuwellis Business Description

Other Exchanges NUWE:USA
Address 12988 Valley View Road, Eden Prairie, MN, USA, 55344
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
19GF Score

Get the complete analysis for STU:22S1

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6,554.73
Price